Visus Therapeutics appoints 6 executive leaders

Ophthalmic pharmaceutical company Visus Therapeutics introduced six new executives it has appointed to lead the company.

Advertisement

The six appointments are Tim Grinstead as COO; James Burke as vice president of research; Patrick Hughes, PhD, as vice president of pharmaceutical development; Lisa Simpson as vice president of clinical operations and compliance; Guru Sharma, OD, as director of ophthalmology and clinical development; and Alex Oh as vice president of intellectual property.

Visus Therapeutics is a clinical-stage company with offices in Seattle and Orange County, Calif.

Advertisement

Next Up in Ophthalmology

  • Southlake, Texas-based Retina Consultants of America has acquired Montana Retina Consultants, according to a Feb. 5 news release.  Bozeman-based Montana…

  • Vision Innovation Partners acquired Ophthalmic Associates of Alexandria (Va.), according to a Feb. 2 press release. Founded in 2010, Ophthalmic…

  • The American Board of Ophthalmology has appointed Steven Gedde, MD, as its next CEO.  Dr. Gedde is an ophthalmologist and…

Advertisement

Comments are closed.